Social Robotics for Autism (SRI)

May 8, 2025 updated by: Flavia Marino, Istituto per la Ricerca e l'Innovazione Biomedica

Social Robotics Intervention for Improving Socio-Pragmatic Skills in Autism: A Randomized Controlled Trial

Socio-pragmatics focuses on the study of language in the context of social interactions. It explores how individuals use language to communicate effectively in specific social situations, taking into consideration the social, cultural and contextual factors that influence communication. Socio-pragmatics analyzes linguistic and nonlinguistic behaviors, such as gestures, facial expressions, tone of voice, and posture, to understand intended meaning, social implications, and shared communicative norms. Children with autism often present difficulties in social-pragmatic skills.

The integration of advanced technologies can play a crucial role in innovative approaches to the development of this skill.

In this experimental protocol, an attempt will be made to demonstrate the effectiveness of training through the use of social robots by comparing the performance of an ASD group performing a treatment using social robots with a control group performing the same in a traditional manner.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Messina, Italy, 98164
        • Italy Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged between 8 and 13 years
  • Clinical diagnosis of ASD according to DSM-5 criteria by a licensed child neuropsychiatrist
  • Verbal and performance IQ > 75 and total IQ > 85, assessed with the WISC-IV
  • No current aggressive behavior or severe oppositional tendencies
  • No hearing, vision, or physical impairments that could interfere with participation
  • Not currently taking any psychotropic medications

Exclusion Criteria:

  • Absence of a clinical diagnosis of ASD based on DSM-5 criteria
  • Verbal or performance IQ ≤ 75, or total IQ ≤ 85 as assessed by WISC-IV
  • Presence of aggressive behavior or severe oppositional tendencies
  • Hearing, vision, or physical impairments that could hinder participation in the intervention
  • Current use of psychotropic medications

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental Group with social robot
Ten children with ASD, aged between 8 and 13 years and with verbal IQs above 75, will be included in the trial following an assessment of their socio-pragmatic skills. They will be randomly assigned to either the control group or the experimental group. Participants in the experimental group will undergo an intervention aimed at developing and/or enhancing socio-pragmatic skills through the mediation of a social robot.
The training sessions were carried out following a strict order. The first phase was dedicated to improving group social skills. The beginning of the session was dedicated to greetings between participants and questions of social interest. During the second phase, videos were shown and participants answered targeted questions asked by the Nao Robot to understand if the child had correctly interpreted the general meaning of the story and to determine the degree of awareness that the expression should be understood in a non-literal sense. In the third phase, a role play was performed among the participants, which re-enacted the situations seen in the videos, involving all the members of the group in turn. During the last phase, participants were asked to share experiences in their lives in which they had used or could have used the pragmatic skill just analyzed. The protocol included 15 phases over 31 sessions, each lasting 45 minutes, twice a week.
Other: Control Group
Ten children with ASD, aged between 8 and 13 years and with verbal IQs above 75, will be included in the trial following an assessment of their socio-pragmatic skills. Children in the control group will follow the same protocol of Experimental Group delivered through a therapist-led group format.
The entire intervention was carried out in a group entirely mediated by an operator without the use of a social robot. The first phase is dedicated to improving group social skills. The beginning of the session was dedicated to greetings between participants and questions of social interest. During the second phase, stories were read and participants answered target questions to understand if the child had correctly interpreted the general meaning of the story and to determine the degree of awareness that the expression should be understood in a non-literal sense. In the third phase, a role play was performed among the participants, in which all members of the group participated in turn, recalling the situations seen in the videos. During the last phase, participants were asked to share experiences from their lives in which they used or could use the pragmatic skill just analyzed. The protocol included 15 phases over 31 sessions, each lasting 45 minutes, twice a week.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wechsler Intelligence Scale for Children 4° edizione (WISC-IV)
Time Frame: Baseline assessment at Day 1 (prior to intervention); the test requires approximately 56-80 minutes to complete.
Wechsler Intelligence Scale for Children 4° edizione (WISC-IV) is a clinical tool for assessing the cognitive abilities of children and young people between the ages of 6 years and 16 years and 11 months.
Baseline assessment at Day 1 (prior to intervention); the test requires approximately 56-80 minutes to complete.
Language Pragmatic Abilities (APL) -MEDEA
Time Frame: Baseline assessment at Day 1 (pre-intervention) and post-intervention assessment at 3 months (at the end of the intervention); each test session lasts approximately 30-45 minutes.

The APL MEDEA is a standardized assessment tool specifically designed to evaluate socio-pragmatic skills in individuals aged 5 to 14 years. This test measures various aspects of pragmatic language skills that are essential for effective communication within social contexts.

The main objective of the APL MEDEA is to assess pragmatic language skills employed during everyday interactions, including the understanding and appropriate use of language in various social situations, recognition of social cues, and effective conversational strategies. The total score ranges from 0 to 68.

Baseline assessment at Day 1 (pre-intervention) and post-intervention assessment at 3 months (at the end of the intervention); each test session lasts approximately 30-45 minutes.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Flavia Marino, Italy Institute for Biomedical Research and Innovation (IRIB) - National Research Council (CNR)

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2024

Primary Completion (Actual)

October 30, 2024

Study Completion (Actual)

November 30, 2024

Study Registration Dates

First Submitted

April 24, 2025

First Submitted That Met QC Criteria

May 8, 2025

First Posted (Actual)

May 15, 2025

Study Record Updates

Last Update Posted (Actual)

May 15, 2025

Last Update Submitted That Met QC Criteria

May 8, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on Experimental Group

Subscribe